"Thrombogenicity" Pronounce,Meaning And Examples
"Thrombogenicity" Natural Recordings by Native Speakers
"Thrombogenicity" Meaning
The term "thrombogenicity" refers to the tendency of a substance or material to promote the formation of thrombi (blood clots) or thrombosis, i.e., the process of blood clotting. In medical and scientific contexts, thrombogenicity is often discussed in terms of the risk of venous or arterial thrombosis, and is associated with various factors such as materials, devices, and drugs that may interact with the blood coagulation cascade.
In a broader sense, thrombogenicity can also refer to the ability of a material to cause blood clotting or thrombosis in a biological system, such as a wound or an implant.
"Thrombogenicity" Examples
5 Usage Examples for the Word "Thrombogenicity"
1. Research Papers
In a recent medical journal, researchers highlighted the thrombogenicity of a new type of cardiac valve, warning of increased risks for blood clots.
Example Sentence: The introduction of the durable new valve had the potential to mitigate thrombogenicity by using more biocompatible materials.
2. Medical Textbooks
A leading textbook on cardiology explains the mechanisms behind thrombogenicity in cardiovascular diseases, including the role of air bubbles in causing thrombi.
Example Excerpt: Thrombogenicity refers to the ability of a particular surface or material to initiate or promote the formation of blood clots.
3. Clinical Case Studies
In a study of patient outcomes after undergoing hip replacement surgery, the surgeon noted an increased incidence of thrombogenicity associated with the new prosthetic material.
Example Summary: While the new implant demonstrated excellent durability and mechanical stability, it presented an elevated thrombogenicity profile.
4. Academic Conference Presentations
A team of researchers presented their findings on the development of a novel antithrombogenic coating for medical devices, highlighting its potential to minimize thrombosis risk.
Example Abstract: Our study aimed to evaluate the efficacy of a new coating in reducing thrombogenicity on implant surfaces.
5. Biotechnology Patent Applications
A biotech firm developed a therapeutic treatment aimed at mitigating thrombogenicity in patients with acute coronary syndrome, citing improved patient outcomes and reduced morbidity.
Example Patent Description: Our innovative drug has the potential to decrease thrombogenicity by inhibiting the activation of key coagulation factors.
"Thrombogenicity" Similar Words
Thrombocytopoiesis
Thrombocytopoiesis refers to the process of forming and developing platelets, which are small blood cells that play a crucial role in blood clotting. It is a complex process that involves the production of platelets from hematopoietic stem cells in the bone marrow, through a series of maturation steps, before they are released into the bloodstream.
Thrombocytosis
Thromboelastography
Thromboembolic
Relating to the formation of a blood clot (thrombus) in a vein or artery that breaks loose and travels to another part of the body, where it can block circulation and cause a serious medical condition, often leading to a stroke or heart attack.
Thromboembolism
A blood clot (thrombus) that breaks loose and travels through the bloodstream until it lodges in a narrower part of a blood vessel, blocking the flow of blood. This condition can occur in the brain, lungs, heart, or other parts of the body and can be life-threatening.
Thromboembolytic
Thromboembolic refers to the formation of a blood clot (thrombus) that breaks loose, travels through the bloodstream, and lodges in another part of the body, causing a blockage (embolism).<br><br>In medical terms, a thromboembolism occurs when a blood clot forms in a vein or an artery and travels through the bloodstream until it gets stuck, blocking normal blood flow to an organ or tissue.<br><br>Examples:<br><br> Pulmonary embolism: a blood clot in the lungs<br> Cerebral embolism: a blood clot in the brain<br> Deep vein thrombosis (DVT): a blood clot in the deep veins of the legs
Thrombogenesis
Thrombogenesis refers to the formation or creation of a blood clot. It's a crucial process in the body, but excessive or abnormal thrombogenesis can lead to various health issues such as cardiovascular diseases, strokes, and pulmonary embolism.
Thrombogenic
Thrombogenic refers to the tendency of a substance, surface, or event to induce the formation of a blood clot (thrombus). In other words, it's the capacity to promote the creation of a blood clot, which can lead to blockages in blood vessels and potentially cause serious health problems, such as thrombosis or ischemia. This term is often used in medical and biomedical contexts to describe materials, devices, or situations that may increase the risk of blood clotting.
Thrombokinase
Thrombokinase is an enzyme involved in the process of blood clotting. It activates prothrombin, a protein in the blood, to form thrombin, which then converts fibrinogen into fibrin to form blood clots.
Thrombolic
The word "thrombolic" refers to a substance or agent that promotes the formation of blood clots (thrombi) or contributes to thrombosis, which is the process of blood clotting. This term is often used in medical contexts.<br><br>There are two main types of thrombolic agents:<br><br>1. Thrombolytic agents: These are substances that dissolve existing blood clots, such as alteplase or streptokinase, which are used to treat acute ischemic stroke, pulmonary embolism, and myocardial infarction.<br>2. Thrombogenic agents: These are substances that increase the tendency of blood to clot, such as those found in certain medical devices or materials that may come into contact with the bloodstream.<br><br>In both cases, thrombolic refers to the promotion of thrombosis, either by dissolving or forming blood clots.
Thrombolytic
Thrombolytic refers to the breakdown or dissolving of blood clots, particularly those that occur in the cardiovascular system.
Thrombolytics
Thrombolytics refer to a type of medication or therapy that helps to dissolve blood clots (thrombi) that have formed in the blood vessels, such as in cases of deep vein thrombosis, pulmonary embolism, or stroke.
Thrombomodulin
Thrombopenia
Thrombopenia is a term that refers to a medical condition characterized by a low platelet count in the blood. Platelets, also known as thrombocytes, are small cell-like components in the blood that play a crucial role in blood clotting, which helps to stop bleeding when a blood vessel is injured. bình
Thrombophilia
Thrombophilia refers to a medical condition characterized by an increased tendency to form blood clots (thrombi) in the blood vessels. It can be caused by a variety of factors, including genetic mutations, infections, medications, or other underlying medical conditions.<br><br>There are several types of thrombophilia, including:<br><br>1. Hereditary thrombophilia: This is a genetic disorder that affects the production of proteins necessary for blood clotting, such as proteins C and S, antithrombin, and factor V Leiden.<br>2. Acquired thrombophilia: This type is caused by external factors, such as pregnancy, obesity, smoking, and certain medications, that increase the risk of blood clotting.<br><br>Symptoms of thrombophilia can include:<br><br> Pain, swelling, and redness in the affected limb<br> Shortness of breath<br> Chest pain or coughing up blood<br> Leg pain or swelling<br> Heat or redness in the affected area<br><br>Treatment for thrombophilia may involve medications to prevent blood clots, such as anticoagulants, and lifestyle changes, such as regular exercise and a balanced diet.